Hospital practice (1995)
-
Hospital practice (1995) · Feb 2014
Randomized Controlled TrialEfficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia.
Few publications of prospective studies have described patient outcomes in community-acquired bacterial pneumonia (CABP)-associated bacteremia. Our objective, in performing this subgroup analysis, was to assess outcomes in subjects with CABP-associated bacteremia in 2 randomized, double-blind clinical studies comparing treatment with ceftaroline fosamil versus ceftriaxone. ⋯ In subjects with CABP-associated bacteremia, ceftaroline fosamil demonstrated similar clinical outcomes at Day 4, end of therapy, and test of cure compared with ceftriaxone.